Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +14.1% | +14.0% | 3 / 3 | +9.9% | +2.33 pp | +0.82 pp | +22.1% | 0.58 | 5.14 | 77,5 | +9,9% | 18,4 | +13,8% | 5.14 | 8.55 | −39,8% |
| Pts | 0 | 0 | 12 | 0 | 8 | 8 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 15.750 (close price on 2026-10-19)EPS (TTM): 3.062
Financial charts
1.Revenue & growth
VND bn77,5Q2/26
1.Revenue & growth
VND bn77,5Q2/26
2.Profit & growth
VND bn18,4Q2/26
3.Profit mix (Penman)
VND bn97,4Q2/26
4.Margins & cost structure
%42.4%Q2/26
5.Returns & cash cycle
% · days19.8%Q2/26
6.Earnings quality & cash
VND bn67,2Q2/26
7.Asset structure
VND bn638Q2/26
8.Funding & debt health
VND bn · times638Q2/26
9.Revenue backlog
VND bn3,80Q2/26
10.Valuation
times · %5,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %672Q2/26
Adjusted EPS growth, latest quarter
14.1%
Average adjusted EPS growth, 3 quarters
14.1%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.2%
Source: vnstockData through Q2/26